Business news

    ASX200 rallies; Splitit rebounds on new product launch; Impedimed soars on FDA clearance

    Article Image
    Highlights
    • ASX200 is trading 0.51% higher today at 7033.5 at 1:30pm AEST.
    • Splitit rebounds today on the launch of new payment gateway service.
    • Impedimed rallies on FDA clearance for SOZO heart monitor.

    The tech sector is trending higher today as Megaport surges more than 7%, also leading the ASX200 gainers, after releasing strong Q3 results.

    The Australian market is see-sawing today, currently trading boosted by modest gains amongst the banks and gold miners.

    Bitcoin is trading 3.14% lower in the last 24-hours at US$53,886.94 at 1:30pm AEST.

    BNPL provider Splitit has rebounded from yesterday?s slide to rally today after announcing the launch of a new payment gateway exclusively designed for instalment payments. The ?Splitit Plus? service is an integrated payment gateway in partnership with US payment processing leader, Stripe.

    Making headlines, Australian-based medical tech company Impedimed surged more than 10% this morning after sharing the news of FDA clearance for its new SOZO heart monitoring device in the US.

    ANYbotics is giving Boston Dynamics a run for its money with today?s announcement of plans to position its ANYmal robotic dog as an ?end-to-end robotic inspection solution? specifically to patrol sites like energy or industrial plants where it?s not safe for humans to be 24/7.

    Disclaimer

    Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relates to your unique circumstances. Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of, or reliance on the information provided directly or indirectly by use of this platform.

    Publisher
    Grafa